ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

OTLK Outlook Therapeutics Inc

8,49
-0,01 (-0,12%)
Nach Börsenschluss
Zuletzt aktualisiert: 23:32:08
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Outlook Therapeutics Inc OTLK NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,01 -0,12% 8,49 23:32:08
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
8,60 8,2703 8,605 8,49 8,50
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202415:05GLOBEOutlook Therapeutics® to Present at the Retina World..
29.4.202415:00GLOBEOutlook Therapeutics® to Present at the Ophthalmology..
15.4.202422:15GLOBEOutlook Therapeutics® Announces Closing of Private Placement..
22.3.202412:35GLOBEOutlook Therapeutics® Receives European Union Positive CHMP..
18.3.202422:10GLOBEOutlook Therapeutics® Announces Closing of Private Placement..
12.3.202413:05GLOBEOutlook Therapeutics® Announces Effective Date for 1-for-20..
11.3.202421:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:16EDGAR2Form 8-K - Current report
14.2.202423:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.2.202422:40EDGAR2Form 8-K - Current report
14.2.202414:05GLOBEOutlook Therapeutics® Reports Financial Results for First..
08.2.202413:00EDGAR2Form ARS - Annual Report to Security Holders
08.2.202412:59EDGAR2Form DEF 14A - Other definitive proxy statements
31.1.202422:01EDGAR2Form SC 13D/A - General statement of acquisition of..
31.1.202414:05GLOBEOutlook Therapeutics® Doses First Subject in NORSE EIGHT
29.1.202423:00EDGAR2Form PRE 14A - Other preliminary proxy statements
24.1.202423:00EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
24.1.202412:02EDGAR2Form 8-K - Current report
23.1.202414:00GLOBEOutlook Therapeutics® Receives FDA Agreement Under Special..
22.12.202323:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22.12.202322:15EDGAR2Form 8-K - Current report
22.12.202314:05GLOBEOutlook Therapeutics® Reports Financial Results for Fiscal..
19.12.202314:05GLOBEOutlook Therapeutics® Submits Special Protocol Assessment..
18.12.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
06.12.202323:00EDGAR2Form 8-K - Current report
06.12.202314:05GLOBEOutlook Therapeutics® Announces Strategic Organizational..
04.12.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
29.11.202322:01EDGAR2Form SC 13D/A - General statement of acquisition of..
28.11.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
27.11.202314:05GLOBEOutlook Therapeutics® Announces Receipt of Type A Meeting..
21.11.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
14.11.202314:05GLOBEOutlook Therapeutics® Adds Global Commercial Expertise with..
14.11.202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
02.11.202313:12EDGAR2Form 8-K - Current report
02.11.202313:05GLOBEOutlook Therapeutics® Provides Update on Type A Meetings..
01.11.202313:05GLOBEOutlook Therapeutics® to Present at Guggenheim’s 5th Annual..
20.10.202323:00EDGAR2Form 8-K - Current report
05.10.202323:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.10.202323:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.10.202323:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.10.202323:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.9.202314:05GLOBEOutlook Therapeutics® Requests Type A Meeting With FDA
21.9.202314:05GLOBEOutlook Therapeutics® to Present at the 2023 Cantor..
05.9.202314:05GLOBEOutlook Therapeutics® to Present at the H.C. Wainwright 25th..
30.8.202312:21EDGAR2Form 8-K - Current report
30.8.202312:00GLOBEOutlook Therapeutics® Provides Regulatory Update on FDA..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock